CPC C07F 15/006 (2013.01) [A61K 31/66 (2013.01); A61P 35/00 (2018.01)] | 17 Claims |
1. A compound of the Formula (I)
or a pharmaceutically acceptable salt, stereoisomer, hydrate, or solvate thereof wherein,
R1 is phenyl optionally substituted with one or more substituents independently selected from linear or branched C1-4 alkyl, hydroxyl, and —SO3H,
R2 is independently selected from halogen, —NCS, —SCN, N3, and —OOCCH3, and —OS(CH3)2,
R is (CH2)y, wherein y is 1-3,
R3 is independently one or more substituents selected from hydrogen, and —O(CH2CH2O)xR4, provided that at least one R3 is not hydrogen, wherein x is 1-3,
R4 is independently selected from hydrogen, —CH2CH2OH, and —CH2CH2R5, a folic acid group, a monosaccharide group, a disaccharide group, and a fatty acid group,
R5 is C1-4 alkoxy.
|